{"id":"https://openalex.org/W4282965295","doi":"https://doi.org/10.1158/1538-7445.am2022-3095","title":"Abstract 3095: Breaking the crosstalk of the cellular tumorigenic network in NSCLC by a highly effective drug combination","display_name":"Abstract 3095: Breaking the crosstalk of the cellular tumorigenic network in NSCLC by a highly effective drug combination","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282965295","doi":"https://doi.org/10.1158/1538-7445.am2022-3095"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-3095","doi":"https://doi.org/10.1158/1538-7445.am2022-3095","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3095","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062790616","display_name":"Dennis G\u00fcrgen","orcid":"https://orcid.org/0000-0001-9241-6537","observed_orcids":["https://orcid.org/0000-0001-9241-6537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis G\u00fcrgen","raw_affiliation_strings":["1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028255654","display_name":"Theresia Conrad","orcid":"https://orcid.org/0000-0002-9497-4716","observed_orcids":["https://orcid.org/0000-0002-9497-4716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theresia Conrad","raw_affiliation_strings":["1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060122908","display_name":"Michael A. Becker","orcid":"https://orcid.org/0000-0002-9706-905X","observed_orcids":["https://orcid.org/0000-0002-9706-905X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Becker","raw_affiliation_strings":["1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011621128","display_name":"Susanne Sebens","orcid":"https://orcid.org/0000-0001-6582-0083","observed_orcids":["https://orcid.org/0000-0001-6582-0083"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Susanne Sebens","raw_affiliation_strings":["2University Medical Center Schleswig Holstein (UKSH), Kiel, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University Medical Center Schleswig Holstein (UKSH), Kiel, Germany;","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024583139","display_name":"Christoph R\u00f6cken","orcid":"https://orcid.org/0000-0002-6989-8002","observed_orcids":["https://orcid.org/0000-0002-6989-8002"]},"institutions":[{"id":"https://openalex.org/I4210112713","display_name":"University Hospital Schleswig-Holstein","ror":"https://ror.org/01tvm6f46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210112713"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph R\u00f6cken","raw_affiliation_strings":["2University Medical Center Schleswig Holstein (UKSH), Kiel, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University Medical Center Schleswig Holstein (UKSH), Kiel, Germany;","institution_ids":["https://openalex.org/I4210112713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002682008","display_name":"Jens Hoffmann","orcid":"https://orcid.org/0000-0003-3880-1658","observed_orcids":["https://orcid.org/0000-0003-3880-1658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens Hoffmann","raw_affiliation_strings":["1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Experimental Pharmacology and Oncology (EPO), Berlin, Germany;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091060463","display_name":"Stefan Langhammer","orcid":"https://orcid.org/0000-0002-7572-4164","observed_orcids":["https://orcid.org/0000-0002-7572-4164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Langhammer","raw_affiliation_strings":["3Life Science Consulting, Burgwedel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Life Science Consulting, Burgwedel, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"3095","last_page":"3095"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7279999852180481},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9240000247955322},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/etoricoxib","display_name":"etoricoxib","score":0.9419999718666077},{"id":"https://openalex.org/keywords/plerixafor","display_name":"plerixafor","score":1.0},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8600000143051147},{"id":"https://openalex.org/keywords/paracrine-signaling","display_name":"paracrine signaling","score":0.7490000128746033},{"id":"https://openalex.org/keywords/crosstalk","display_name":"crosstalk","score":0.5899999737739563},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.800000011920929},{"id":"https://openalex.org/keywords/adenocarcinoma","display_name":"adenocarcinoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4189999997615814},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8012414574623108},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5967499017715454},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5949233770370483},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47980573773384094},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4453504979610443},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4110984206199646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38934722542762756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3634644150733948},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34716397523880005}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-3095","doi":"https://doi.org/10.1158/1538-7445.am2022-3095","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-3095","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3209806815","https://openalex.org/W4205732799","https://openalex.org/W2602837436","https://openalex.org/W4415942105","https://openalex.org/W4390742745","https://openalex.org/W2898549510","https://openalex.org/W2148958178","https://openalex.org/W2900496369","https://openalex.org/W2005048851","https://openalex.org/W2044312211"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Non-small":[2],"cell":[3,113],"lung":[4],"cancer":[5],"(NSCLC)":[6],"is":[7,205],"commonly":[8],"diagnosed":[9],"at":[10],"advanced":[11,244],"stages":[12],"with":[13,45,154],"limited":[14],"treatment":[15,93,142,264],"options":[16],"particularly":[17],"in":[18,73,158,181,202,219,243,260,307],"tumors":[19,105,204],"without":[20,115,177,248],"targetable":[21,249],"driver":[22,117,250],"mutations.":[23],"Methods:":[24],"Considering":[25],"previously":[26],"published":[27],"criteria":[28],"for":[29,33,87,99,212,225,239,322],"selecting":[30],"drug":[31,35,62,80,124,210,313],"combinations":[32],"overcoming":[34],"resistances1,":[36],"we":[37,57,190],"have":[38],"established":[39],"a":[40,135,237,240,261,310],"low":[41,91,169,262],"dose":[42,92,170,263],"combination":[43,221,314],"therapy":[44,171,268],"cabozantinib,":[46,255],"afatinib,":[47,256],"etoricoxib":[48,259],"and":[49,78,111,134,163,176,208,228,258,276],"plerixafor.":[50],"Utilizing":[51],"NSCLC":[52,203,246,308],"patient-derived":[53],"xenograft":[54],"(PDX)":[55],"models":[56],"aimed":[58],"to":[59,64,75,84,127],"use":[60],"this":[61,123,168,182,220],"regimen":[63,125,172,222,265],"disrupt":[65],"paracrine":[66],"substitutional":[67],"signaling":[68],"within":[69],"the":[70,90,148,151,164,187,198,216,253,300,303,319],"tumorigenic":[71,200,305],"network":[72,201,306],"order":[74],"circumvent":[76],"pre-existing":[77],"adaptive":[79],"resistances.":[81],"In":[82],"contrast":[83],"daily":[85],"dosing":[86],"respective":[88],"monotherapies":[89],"was":[94,173],"paused":[95],"every":[96],"five":[97],"days":[98],"two":[100],"days.":[101],"Result:":[102],"All":[103,214],"PDX":[104],"treated,":[106],"including":[107],"highly":[108,206,311],"therapy-resistant":[109],"adeno-":[110],"squamous":[112],"carcinomas":[114],"identifiable":[116],"mutations,":[118],"were":[119],"completely":[120],"suppressed":[121],"by":[122,309],"leading":[126],"an":[128],"Objective":[129],"Response":[130],"Rate":[131,138],"of":[132,139,150,167,195,215,271,302,318],"81%":[133],"Clinical":[136],"Benefit":[137],"100%.":[140],"After":[141],"discontinuation":[143],"growth":[144],"suppression":[145],"remained":[146],"until":[147],"end":[149],"follow-up":[152],"period":[153],"only":[155],"slight":[156],"increase":[157],"tumor":[159],"growth.":[160],"The":[161],"application":[162],"safety":[165],"profile":[166],"well":[174],"manageable":[175],"pronounced":[178],"side":[179],"effects":[180],"pre-clinical":[183],"setting.":[184],"Discussion:":[185],"For":[186],"first":[188],"time":[189],"show":[191],"that":[192],"simultaneous":[193],"inhibition":[194],"pathways":[196],"forming":[197],"cellular":[199,304],"effective":[207,312],"overcomes":[209],"resistances":[211],"monotherapies.":[213],"drugs":[217,254],"used":[218],"are":[223],"approved":[224],"different":[226],"indications":[227],"therefore":[229],"readily":[230],"available.":[231],"Conclusion:":[232],"Our":[233],"results":[234],"emphatically":[235],"encourage":[236],"setup":[238],"clinical":[241],"study":[242],"stage":[245],"patients":[247],"mutations":[251],"combining":[252],"plerixafor":[257],"as":[266],"novel":[267],"strategy.":[269],"Indication":[270],"Source:":[272],"1.":[273],"Langhammer":[274],"S":[275],"Scheerer":[277],"J.":[278],"Oncotarget":[279],"8,":[280],"43555-43570":[281],"(2017).":[282],"Citation":[283],"Format:":[284],"Dennis":[285],"G\u00fcrgen,":[286],"Theresia":[287],"Conrad,":[288],"Michael":[289],"Becker,":[290],"Susanne":[291],"Sebens,":[292],"Christoph":[293],"R\u00f6cken,":[294],"Jens":[295],"Hoffmann,":[296],"Stefan":[297],"Langhammer.":[298],"Breaking":[299],"crosstalk":[301],"[abstract].":[315],"In:":[316],"Proceedings":[317],"American":[320],"Association":[321],"Cancer":[323,334],"Research":[324],"Annual":[325],"Meeting":[326],"2022;":[327],"2022":[328],"Apr":[329],"8-13.":[330],"Philadelphia":[331],"(PA):":[332],"AACR;":[333],"Res":[335],"2022;82(12_Suppl):Abstract":[336],"nr":[337],"3095.":[338]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2022-06-17T00:00:00"}